23
https://pubmed.ncbi.nlm.nih.gov/38114907
This study found that using siRNA to reduce the expression of ureB and cagA virulence factors in Helicobacter pylori strain SS1 inhibited urease enzyme activity and may be a promising strategy for developing RNAi-based anti-H. pylori therapies.